KR970005310B1 - The process of preparing benzoxazine derivatives - Google Patents
The process of preparing benzoxazine derivatives Download PDFInfo
- Publication number
- KR970005310B1 KR970005310B1 KR1019930024782A KR930024782A KR970005310B1 KR 970005310 B1 KR970005310 B1 KR 970005310B1 KR 1019930024782 A KR1019930024782 A KR 1019930024782A KR 930024782 A KR930024782 A KR 930024782A KR 970005310 B1 KR970005310 B1 KR 970005310B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- substituted amino
- prepare
- amino group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
본 발명은 아래 일반식(Ⅰ)의 9-할로-7-옥소-2,3-디히드로-7H-피리도[1,2,3-de][1.4]벤즈옥사진-6-카르복실산 유도체 및 제약상으로 허용되는 그 염의 제조방법에 관한 것이다.The present invention relates to 9-halo-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1.4] benzoxazine-6-carboxylic acid of the general formula (I) It relates to a derivative and a method for preparing a pharmaceutically acceptable salt thereof.
상기식에서 X는 할로겐 원자를 나타내고, R은 수소원자 또는 탄소 원자수 1에서 6의 알킬기를 표시하고, A는 단일 치환된 아미노기 또는 이 치환된 아미노기 또는 다른 헤테로원자를 함유하는 환상 치환 아미노기를 나타낸다. 단일 치환된 아미노기의 예로서 모노메틸 아미노기, 모노에틸 아미노기를 포함하며, 이 치환된 아미노기는 디메틸 아미노기, 디에틸 아미노기를 포함한다. 환상 치환 아미노기는 4에서 7원환을 가지는 아미노기를 말하여 그예로서, 아제티디닐, 피롤리디닐, 모르폴리닐, 페페라지닐 및 호모피레라지닐이 포함되며, 보다 상세하게는 4-메틸-1-피페라지닐, 1-피페라지닐, 1-피놀리디닐, 3-히드록시-4모르폴리닐, 4-(2-히드록시 에틸)피페라지닐, 3,5-디메틸-1-피페라지닐, 4-디메틸아미노-1-피페리디닐, 호모피페라지닐, 1-피라졸리딜, 2-메틸-1-피라졸리딜 등을 의미한다.Wherein X represents a halogen atom, R represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and A represents a cyclic substituted amino group containing a single substituted amino group or a substituted amino group or another heteroatom. Examples of a single substituted amino group include a monomethyl amino group and a monoethyl amino group, and the substituted amino group includes a dimethyl amino group and a diethyl amino group. A cyclic substituted amino group refers to an amino group having a 4 to 7 membered ring, for example, azetidinyl, pyrrolidinyl, morpholinyl, pepperrazinyl and homopyrerazinyl, more specifically 4-methyl-1 Piperazinyl, 1-piperazinyl, 1-pinolidinyl, 3-hydroxy-4morpholinyl, 4- (2-hydroxyethyl) piperazinyl, 3,5-dimethyl-1-pipera Genyl, 4-dimethylamino-1-piperidinyl, homopiperazinyl, 1-pyrazolidyl, 2-methyl-1-pyrazolidyl and the like.
본 발명의 화합물에 대한 제조방법으로서 대한민국 특허공보(B1) 공고 제84-2141호의 내용을 반응경로로 나타내면 아래와 같다.As a preparation method for the compound of the present invention, the contents of Korean Patent Publication (B1) Publication No. 84-2141 are represented by the reaction route as follows.
위 식에서, X, A, R은 앞에서 정의한 바와 같다.In the above formula, X, A, R are as defined above.
이에 대하여, 본 발명은 짧은 반응경로와 높은 순도로 화합물(Ⅰ)을 제조하는 방법에 관한 것으로서, 종래의 위와 같은 방법과는 전혀 다른 반응경로를 갖는 것이 특징이며, 이러한 본 발명의 반응경로를 기술하면 다음과 같다.On the other hand, the present invention relates to a method for preparing compound (I) with a short reaction route and high purity, characterized in that it has a completely different reaction route from the conventional method as described above, and describes such a reaction route of the present invention. Is as follows.
위 식들에서, X, R, A은 앞에서 정의한 바와 같다.In the above formulas, X, R and A are as defined above.
본 발명을 상세히 설명하면 아래와 같다.Hereinafter, the present invention will be described in detail.
일반식(Ⅱ)의 방향족 아민과 일반식(Ⅲ)의 2-케토알코올을 반응시킨 후 소듐보로하이드라이드와 같은 환원제로 환원을 시켜 일반식(Ⅳ)에 해당하는 방향족 아민 유도체를 제조한다.The aromatic amine derivative of Formula (IV) is prepared by reacting the aromatic amine of Formula (II) with 2-ketoalcohol of Formula (III), followed by reduction with a reducing agent such as sodium borohydride.
일반식(Ⅱ)의 방향족 아민에 대하여 일반식(Ⅲ)의 2-케토알코올을 1.0 내지 2.0당량을 사용하여 메탄올, 에탄올과 같은 극성 유기용매에서 반응을 실시하거나 또는 반응용매 없이 직접 반응을 실시하여 반응을 시키는데, 반응기는 가압반응기로서 완전히 밀폐될 수 있는 반응기를 사용하여 3-6시간 환류시킨 후 상온에서 냉각한다.Reaction of the 2-ketoalcohol of the general formula (III) with 1.0 to 2.0 equivalents of the aromatic amine of the general formula (II) is carried out in a polar organic solvent such as methanol or ethanol or directly without the reaction solvent. The reactor is refluxed for 3-6 hours using a reactor that can be completely sealed as a pressurized reactor and then cooled at room temperature.
일반식(Ⅱ)의 아민에 대해 0.5 내지 1.0당량의 소듐보로하이드라이드를 반응용기에 투입하여 상온에서 3-5시간 반응시킨 후, 추출, 건조, 여과, 증발 및 이들의 조합된 기술로서 일반식(Ⅳ)에 해당하는 방향족 아민을 얻는다.0.5 to 1.0 equivalent of sodium borohydride was added to the reaction vessel with respect to the amine of formula (II) to react for 3-5 hours at room temperature, followed by extraction, drying, filtration, evaporation, and a combination thereof. The aromatic amine corresponding to formula (IV) is obtained.
얻어진 일반식(Ⅳ)의 화합물을 소듐하이드라이브(NaH), 포타슘하이드라이브(KH), 포타슘플루오라이드(KF), 소듐알콕사이드(RONa), 포타슘알콕사이드(ROK)와 같은 강염기 존재하에서 반응을 시켜 일반식(Ⅴ)의 화합물을 얻는데, 이때 반응조건으로서는 용매로서 디옥산, 디메틸포름아미드 등을 사용하고 반응온도는 70-150℃, 반응시간은 1-3시간이 바람직하다.The obtained compound of formula (IV) is reacted in the presence of strong bases such as sodium hydride (NaH), potassium hydride (KH), potassium fluoride (KF), sodium alkoxide (RONa) and potassium alkoxide (ROK) Obtaining the compound of Formula (V), At this time, dioxane, dimethylformamide, etc. are used as reaction conditions, The reaction temperature is 70-150 degreeC, The reaction time is 1-3 hours.
얻어진 일반식(Ⅴ)의 화합물을 디에틸에톡시메틸렌 말로네이트 또는 디메틸메톡시메틸렌 말로네이트와 반응시켜 일반식(Ⅵ)의 화합물을 얻는다. 이때 반응조건으로서는 용매 존재하에서 혹은 용매없이 직접 일반식(Ⅴ)의 화합물과 디에틸에톡시메틸렌 말로네이트 혹은 디메틸메톡시메틸렌 말로네이트를 100-200℃의 온도에서 2-6시간 정도 반응시킨 후 상온으로 냉각하여 반응도중에 생긴 에탄올을 감압하에서 증류하여 제거하고, 여기서 디페닐에테르와 같은 높은 비등점을 가지는 용매를 사용하여 150-250℃의 온도에서 2-4시간 정도 고리화반응을 시킨 후 상온으로 냉각하여 일반식(Ⅵ)의 화합물을 얻는다.The obtained compound of formula (V) is reacted with diethylethoxymethylene malonate or dimethylmethoxymethylene malonate to obtain a compound of formula (VI). At this time, as the reaction conditions, the compound of general formula (V) and diethylethoxymethylene malonate or dimethylmethoxymethylene malonate are reacted at a temperature of 100-200 ° C. for 2-6 hours directly in the presence of a solvent or without solvent. The ethanol generated during the reaction was distilled off under reduced pressure, and then cyclized at a temperature of 150-250 ° C. for 2-4 hours using a solvent having a high boiling point such as diphenyl ether, followed by cooling to room temperature. To obtain a compound of formula (VI).
또한 고리화 반응시 디메틸에테르를 용매에서 폴리포스포릭 산 혹은 그 에스테르를 촉매로 사용할 수 있으며, 또는 디페닐에테르 용매없이 폴리포스포릭 산 혹은 그 에스테르를 촉매 겸 용매로 사용하여 반응을 시킬 수 있다.In addition, polyphosphoric acid or its ester may be used as a catalyst in the solvent in the cyclization reaction, or polyphosphoric acid or its ester may be used as the catalyst and solvent without the diphenyl ether solvent.
일반식(Ⅵ)의 화합물을 가수분해하여 일반식(Ⅶ)의 화합물을 얻는데 가수분해 조건은 산 또는 염기 조건하에서 모두 가능하며, 물, 디옥산, 메탄올, 에탄올 및 이들의 혼합용매에서 수산화나트륨, 수산화칼륨 등과 같은 염기로서 60-120℃ 정도에서 1-4시간 정도 반응을 시킨 후 반응혼합물을 냉각하여 초산 또는 염산으로 처리하여 고체를 생성시키거나, 또는 염산, 초산 또는 이들의 혼합액에서 일반식(Ⅵ)의 화합물을 60-120℃의 온도에서 1-4시간 정도 반응을 시킨 후 상온으로 냉각하여 생성된 고체를 여과, 증발, 재결정 및 이들의 조합된 기술의 방법으로 순수한 일반식(Ⅶ)의 화합물을 얻는다.The compound of formula (VI) is hydrolyzed to obtain a compound of formula (V). The hydrolysis conditions are all possible under acidic or basic conditions, and sodium hydroxide in water, dioxane, methanol, ethanol, and a mixed solvent thereof. After reacting with a base such as potassium hydroxide for about 1-4 hours at about 60-120 ° C., the reaction mixture is cooled and treated with acetic acid or hydrochloric acid to produce a solid, or a general formula (HCl) in After reacting the compound of VI) at a temperature of 60-120 ° C. for 1-4 hours and cooling to room temperature, the solid produced was filtered, evaporated, recrystallized, and a combination of these techniques to obtain a pure general formula. Obtain the compound.
얻어진 일반식(Ⅶ)의 화합물을 일반식 AH의 아민화합물과 반응시켜 목적물인 일반식(Ⅰ)의 화합물을 얻는데, 이때 반응조건으로서는 몰비로 1.2-5.0당량에 해당하는 일반식 AH의 아민과 일반식(Ⅶ)의 화합물을 디메틸포름아미드, 디메틸술폭시드와 같은 극성용매를 사용하여 100-150℃의 온도에서 10-20시간 반응시킨 후 상온으로 냉각하여 여과, 추출, 증발, 재결정 및 이들의 조합된 기술의 방법으로 순수한 일반식(Ⅰ)의 화합물을 얻을 수 있으며, 얻어진 일반식(Ⅰ)의 화합물은 독성이 적으며 그램 음성균 및 그램 양성균에 탁월한 항균활성을 지닌다.The obtained compound of formula (VII) is reacted with an amine compound of formula AH to obtain a compound of formula (I) as a target product, wherein the reaction conditions are amines of general formula AH corresponding to 1.2-5.0 equivalents in molar ratio and general The compound of formula (VII) is reacted at a temperature of 100-150 ° C. for 10-20 hours using a polar solvent such as dimethylformamide and dimethyl sulfoxide, cooled to room temperature, filtered, extracted, evaporated, recrystallized and a combination thereof. By the method of the present technique, the pure compound of general formula (I) can be obtained, and the obtained compound of general formula (I) is less toxic and has excellent antimicrobial activity against gram negative bacteria and gram positive bacteria.
다음의 실시예로서 본 발명을 상세히 설명한다.The present invention is explained in detail by the following examples.
실시예 1Example 1
1). N-(1-히드록시프로-2-필)-2,3,4-트리플루오로아닐린의 제조.One). Preparation of N- (1-hydroxypro-2-fil) -2,3,4-trifluoroaniline.
2,3,4-트리플루오로아닐린 5.0g, 아세톨 3.8g을 메탄올 용매에 혼합하여 밀폐시킬 수 있는 반응기에 투입하고 5시간 환류시킨 후 상온으로 냉각하여 소듐보로하이드라이드 1.3g을 반응용기에 투입하고 상온에서 4시간 교반하였다. 반응액을 묽은 염산으로 중화시키고 에테르로 추출한 후 건조, 농축한 후, 잔사를 실리카겔 크로마트그라피로 정제하여 N-(1-히드록시프로-2-필)-2,3,4-트리플루오로아닐린 5.5g을 얻었다.5.0 g of 2,3,4-trifluoroaniline and 3.8 g of acetol are mixed in a methanol solvent and added to a reactor which can be sealed. The mixture is refluxed for 5 hours, cooled to room temperature, and 1.3 g of sodium borohydride is reacted. It was added to and stirred at room temperature for 4 hours. The reaction solution was neutralized with dilute hydrochloric acid, extracted with ether, dried and concentrated, and then the residue was purified by silica gel chromatography to give N- (1-hydroxypro-2-fil) -2,3,4-trifluoro. 5.5 g of aniline were obtained.
2). 7,8-디플루오로-2,3-디히드로-3-메틸-4H-1,4-벤즈옥사진의 제조.2). Preparation of 7,8-difluoro-2,3-dihydro-3-methyl-4H-1,4-benzoxazine.
N-(1-히드록시프로-2-필)-2,3,4-트리플루오로벤젠 3.0g, 포타슘플루오라이드 0.9g을 디메틸포름아미드 50ml에 혼합하여 3시간 환류시킨 후 상온으로 냉각하여 용매를 감압하에서 제거하였다. 잔사에 클로로포름과 물을 넣어 섞어준 다음 유기층을 분리한 후 건조시켜 용매를 감압하 제거하고 잔사를 실리카겔 크로마토그래피로 정제하여 순수한 7,8-디플루오로-2,3-디히드로-3-메틸-4H-1,4-벤즈옥사진 2.2g을 얻었다.3.0 g of N- (1-hydroxypro-2-fil) -2,3,4-trifluorobenzene and 0.9 g of potassium fluoride were mixed in 50 ml of dimethylformamide, refluxed for 3 hours, and then cooled to room temperature to obtain a solvent. Was removed under reduced pressure. After chloroform and water were added to the residue, the organic layer was separated and dried to remove the solvent under reduced pressure, and the residue was purified by silica gel chromatography to obtain pure 7,8-difluoro-2,3-dihydro-3-methyl. 2.2 g of -4H-1,4-benzoxazine was obtained.
3). 9,10-디플루오로-2,3-디히드로-3-메틸-7-옥소-7H-피리도[1,2,3-de][1,4]벤조옥사신-6-카르복실산의 제조.3). 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzooxacin-6-carboxylic acid Manufacturing.
7,8-디플루오로-2,3-디히드로-3-메틸-4H-1,4-벤즈옥사진 3.0g, 디에틸에톡시메틸렌 말로네이트 5.3g을 용매없이 혼합하여 130℃에서 4시간 동안 가열한 후 부산물인 에탄올을 제거하고, 여기에 폴리포스포릭산 에틸 에스테르 20.0g을 넣어 다시 4시간 동안 가열하였다. 반응용기에 찬 물을 넣고 클로로포름으로 추출한 후 클로로포름층을 탄산칼륨 수용액으로 씻어준 후 건조하고 감압 농축하여 얻은 화합물에 초산/염산(2/1) 50ml를 가하여 4시간 동안 환류시켰다. 반응요기를 상온으로 냉각하고 생성된 고체를 여과하여 9,10-디플루오르-2,3-디히드로-3-메틸-7-옥소-7H-피리도[1,2,3-de][1,4]벤즈옥사신-6-카르복실산 2.7g을 얻었다.3.0 g of 7,8-difluoro-2,3-dihydro-3-methyl-4H-1,4-benzoxazine and 5.3 g of diethylethoxymethylene malonate were mixed without a solvent for 4 hours at 130 ° C. After heating for ethanol as a by-product was removed, and 20.0 g of polyphosphoric acid ethyl ester was added thereto, followed by heating for 4 hours. Cold water was added to the reaction vessel, followed by extraction with chloroform. The chloroform layer was washed with an aqueous potassium carbonate solution, dried and concentrated under reduced pressure, and 50 ml of acetic acid / hydrochloric acid (2/1) was added to reflux for 4 hours. The reaction vessel was cooled to room temperature and the resulting solid was filtered to give 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido [1,2,3-de] [1 , 4] 2.7 g of benzoxacin-6-carboxylic acid was obtained.
4). 9,10-플루오로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤조옥사신-6-카르복실산의 제조.4). 9,10-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de] [ 1,4] Preparation of benzooxacin-6-carboxylic acid.
9,10-디플루오로-2,3-디히드로-3-메틸-7-옥소-7H-피리도[1,2,3-de][1,4]벤조옥사신-6-카르복실산 1.0g, N-메틸피페라진 0.5g, 피리딘 1.5g, 디메틸술폭시드 5ml를 혼합하여 120-140℃의 온도에서 12시간 가열한 후 감압하에서 용매를 제거하였다. 반응용기에 물을 넣어 생성된 고체를 여과한 후 에탄올로 재결정하여 순수한 9-플루오로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤조옥사신-6-카르복실산의 제조. 0.84g을 얻었다.9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzooxacin-6-carboxylic acid 1.0 g, N-methylpiperazine 0.5 g, pyridine 1.5 g, and 5 ml of dimethyl sulfoxide were mixed and heated at a temperature of 120-140 ° C. for 12 hours, and then the solvent was removed under reduced pressure. Water was added to the reaction vessel, and the resulting solid was filtered and recrystallized with ethanol to obtain pure 9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7- Preparation of oxo-7H-pyrido [1,2,3-de] [1,4] benzooxacin-6-carboxylic acid. 0.84 g was obtained.
융점 : 250-257℃(분해)Melting Point: 250-257 ℃ (Decomposition)
실시예 2Example 2
실시예 1의 제1공정에서 2,3,4-트리플루오로아닐린 대신에 2,3,4-트리클로로아닐린 5.0g을 투입한 것을 제외하고는 실시예 1과 동일 조건과 방법으로 반응시켜 9-디플루오로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤조옥사진-6-카르복실산 0.82g을 얻었다.Reaction was carried out in the same manner as in Example 1 except that 5.0 g of 2,3,4-trichloroaniline was added instead of 2,3,4-trifluoroaniline in the first step of Example 1 -Difluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de] [1, 4] 0.82 g of benzoxazine-6-carboxylic acid was obtained.
융점 : 275-276℃(분해)Melting Point: 275-276 ℃ (Decomposition)
실시예 3Example 3
실시예 1의 제5공정에서 N-메틸피페라진 대신에 0.45g을 투입하는 것을 제외하고는 실시예 1과 동일 조건과 방법으로 반응시켜 9-할로-7-옥소-2,3-디히드로-7H-피리도[1,2,3-de][1,4]벤조옥사진-6-카르복실산 0.79g을 얻었다.In Example 5, 9-halo-7-oxo-2,3-dihydro- was reacted in the same manner as in Example 1, except that 0.45 g was added instead of N-methylpiperazine. 0.79 g of 7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid was obtained.
융점 : 257-260℃(분해)Melting Point: 257-260 ℃ (Decomposition)
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930024782A KR970005310B1 (en) | 1993-11-19 | 1993-11-19 | The process of preparing benzoxazine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930024782A KR970005310B1 (en) | 1993-11-19 | 1993-11-19 | The process of preparing benzoxazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950014118A KR950014118A (en) | 1995-06-15 |
KR970005310B1 true KR970005310B1 (en) | 1997-04-15 |
Family
ID=19368542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930024782A KR970005310B1 (en) | 1993-11-19 | 1993-11-19 | The process of preparing benzoxazine derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970005310B1 (en) |
-
1993
- 1993-11-19 KR KR1019930024782A patent/KR970005310B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR950014118A (en) | 1995-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840002141B1 (en) | Process for preparing benzoxazine derivatives | |
CA2048511A1 (en) | Tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same | |
KR870001944B1 (en) | Preparation process of quinoline carboxylic acid derivatives | |
US4213985A (en) | Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones | |
IE58312B1 (en) | Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors | |
DK175037B1 (en) | Process for the preparation of quinoline carboxylic acid derivatives and intermediates which may be used in the process | |
KR970005310B1 (en) | The process of preparing benzoxazine derivatives | |
EP0101829B1 (en) | Tricyclic compounds, a process for their production and pharmaceutical compositions containing said compounds | |
KR950008317B1 (en) | The preparation process of benzoxazine derivatives | |
JPH0116837B2 (en) | ||
KR960015032B1 (en) | The process for preparing benzoxazine derivatives | |
KR940004811B1 (en) | Process for preparing benzoxazine derivatives | |
EP0041630B1 (en) | New 3h-naphtho(1,2-d)imidazoles, the process for preparing them, the compounds for use as antiinflammatory agents and compositions containing them | |
KR940009792B1 (en) | Process for preparing benzoxazine carboxylic acid derivatives | |
CA1038870A (en) | Pyrimidine derivatives | |
KR100248370B1 (en) | Preparation of intermediate of (-)-3(s)-methylpyrido benzoxizine derivative | |
JPH02247177A (en) | Benzo(b)(1,8)naphthyridine derivative and preparation thereof | |
NO170153B (en) | PREPARATION OF 1-METHYLAMINOKINOLINCARBOXYL ACID DERIVATIVES | |
FI76345C (en) | FOERFARANDE FOER FRAMSTAELLNING AV PYRIDOBENSOXAZINDERIVAT. | |
KR100494882B1 (en) | A process for preparing (-)-9-Fluoro-2,3-dihydro-3(S)-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | |
JPH02247178A (en) | Benzo(b)(1,8)naphthyridine derivative, preparation thereof, and composition containing same | |
KR100440192B1 (en) | Method of preparing optical active quinolonecarboxylic acid derivatives | |
NO301012B1 (en) | Process for the preparation of benzo-benzaphthyridines | |
KR940004812B1 (en) | Process for preparing benzoxazine derivatives | |
EP0675880B1 (en) | Quinoline disulfides as intermediates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050614 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |